TECTA DIN 02267233
Status: Marketed
Holder: TAKEDA CANADA INC
Molecule: PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM)
Available to quote
Health Canada record
| Active ingredient(s) | PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM) 40 MG |
|---|---|
| Dosage form | Tablet (Enteric-Coated) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A02BC02 PANTOPRAZOLE |
| Original market date | 15-Mar-2006 |
| Current status date | 21-Jun-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Takeda Canada Inc. — licence 101769, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02440628 | TEVA-PANTOPRAZOLE MAGNESIUM | TEVA CANADA LIMITED | Tablet (Delayed-Release) | PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM) 40 MG | Marketed |
| 02441853 | PANTOPRAZOLE MAGNESIUM | ALTIUS HEALTHCARE INC | Tablet (Enteric-Coated) | PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM) 40 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 18785 | 2016-12-13 | Supplement to a New Drug Submission (SNDS) | UPDATE TO THE LABELLING OF THE SAFETY INFORMATION WITH RESPECT TO INTERACTIONWITH ANTIRETROVIRAL PRODUCTS |
| 13963 | 2012-12-21 | New Drug Submission (NDS) | Manufacturer name change |
| 9860 | 2008-10-27 | Supplement to a New Drug Submission (SNDS) | PRODUCT NAME CHANGE |
| 8926 | 2007-07-20 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 6541 | 2005-04-22 | New Drug Submission (NDS) |